Skip to main content
Research

Publications: Prof Jude Fitzgibbon

Gerdes H, Casado P, Dokal A, Hijazi M, Akhtar N, Osuntola R, Rajeeve V, Fitzgibbon J et al. ( 2021 ) . Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs . Nature Communications vol. 12 , ( 1 )
Heward J, Konali L, D'Avola A, Close K, Yeomans A, Philpott M, Dunford J, Rahim T et al. ( 2021 ) . KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas . Blood vol. 138 , ( 5 ) 370 - 381 .
Homan CC, King-Smith SL, Lawrence DM, Arts P, Feng J, Andrews J, Armstrong M, Ha T et al. ( 2021 ) . The RUNX1 Database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy . Haematologica
Rio-Machin A, Fitzgibbon J ( 2021 ) . Germline ETV6 variants: Not ALL created equally . Blood vol. 137 , ( 3 ) 288 - 289 .
Maybury BD, Saavedra-Torres Y, Snoeks TJA, Fitzgibbon J, Calado DP ( 2021 ) . Generation and Surgical Analysis of Genetic Mouse Models to Study NF-κB-Driven Pathogenesis of Diffuse Large B Cell Lymphoma . vol. 2366 , 321 - 342 .
Fitzgibbon J, Weigert O ( 2021 ) . Molecular genetics in indolent lymphomas . Hematologic Malignancies ,
Fitzgibbon J ( 2020 ) . Inherited Myeloid Malignancies . EUROPEAN JOURNAL OF HUMAN GENETICS . vol. 28 , 17 - 17 .
Rio-Machin A, Vulliamy T, Hug N, Walne A, Tawana K, Cardoso S, Ellison A, Pontikos N et al. ( 2020 ) . The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants . Nature Communications vol. 11 , ( 1 )
Rio-Machin A, Casado-Izquierdo P, Miettinen J, Bewicke-Copley F, Khan N, Demeulemeester J, Krizsán S, Zheng J et al. ( 2020 ) . Integration of Deep Multi-Omics Profiling Veals New Insights into the Biology of Poor-Risk Acute Myeloid Leukemia . Blood vol. 136 , ( Supplement 1 ) 39 - 40 .
Uyulur F, Bewicke-Copley F, Anene CA, Schlesner M, MMML-Seq Project I, Siebert R, Okosun J, Fitzgibbon J et al. ( 2020 ) . Systematic Evaluation of Somatic Cis -Regulatory Mutations in Follicular Lymphoma . Blood vol. 136 , ( Supplement 1 ) 26 - 27 .
Larrea E, Fernandez¿mercado M, Guerra¿assunção JA, Wang J, Goicoechea I, Gaafar A, Ceberio I, Lobo C et al. ( 2020 ) . Identification of recurrent mutations in the microrna‐binding sites of b‐cell lymphoma‐ associated genes in follicular lymphoma . International Journal of Molecular Sciences vol. 21 , ( 22 ) 1 - 12 .
Kumar EA, Okosun J, Fitzgibbon J ( 2020 ) . The Biological Basis of Histologic Transformation . Hematology/Oncology Clinics of North America vol. 34 , ( 4 ) 771 - 784 .
Dokal I, Tummala H, Vulliamy T, Walne A ( 2020 ) . A frameshift variant in the specificity protein 1 triggers superactivation of SP1-mediated transcription in familial bone marrow failure . Proceedings of the National Academy of Sciences of USA Article 32636268 ,
Fitzgibbon J, Park S, Cook G, Paiva B, Gloghini A, Van Breda E, Busti F, Garderet L et al. ( 2020 ) . Recent Advancements in Hematology: Knowledge, Methods and Dissemination, Part 1 . Bloods—International Open Access Journal of Hematology vol. 1 , ( 1 )
Araf S, Korfi K, Bewicke-Copley F, Wang J, Cogliatti S, Kumar E, Forrer F, Barrington SF et al. ( 2020 ) . Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma . Haematologica vol. 105 , ( 6 ) E318 - E321 .
Waclawiczek A, Hamilton A, Rouault-Pierre K, Abarrategi A, Albornoz MG, Miraki-Moud F, Bah N, Gribben J et al. ( 2020 ) . Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia . Journal of Clinical Investigation vol. 130 , ( 6 ) 3038 - 3050 .
Cucco F, Barrans S, Sha C, Clipson A, Crouch S, Dobson R, Chen Z, Thompson JS et al. ( 2020 ) . Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit . Leukemia vol. 34 , ( 5 ) 1329 - 1341 .
Maybury B, Fitzgibbon J, Calado D ( 2020 ) . An immunocompetent, spontaneous mouse model of DLBCL for studying the response to R-CHOP and identifying new treatment targets . BRITISH JOURNAL OF HAEMATOLOGY . vol. 189 , 110 - 111 .
Fitzgibbon J, Busca A, Gloghini A, López-Guillermo A, Orazi A, Carlo-Stella C, Andrès E, Van Breda E et al. ( 2020 ) . Recent Advancements in Hematology: Knowledge, Methods and Dissemination . Hemato vol. 1 , ( 1 ) 5 - 6 .
Charrot S, Armes H, Rio-Machin A, Fitzgibbon J ( 2020 ) . AML through the prism of molecular genetics . British Journal of Haematology vol. 188 , ( 1 ) 49 - 62 .
Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, López-Guillermo A, Fitzgibbon J ( 2019 ) . Follicular lymphoma . Nature Reviews Disease Primers vol. 5 , ( 1 )
Jurinovic V, Passerini V, Oestergaard MZ, Knapp A, Mundt K, Araf S, Richter J, Fitzgibbon J et al. ( 2019 ) . Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy . Blood . vol. 134 , 122 - 122 .
Bewicke-Copley F, Korfi K, Araf S, Kumar EA, Cummin TEC, Ashton-Key M, Barrans S, Van Hoppe S et al. ( 2019 ) . Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel . Blood vol. 134 , ( Supplement_1 ) 2769 - 2769 .
Ortega-Molina A, Deleyto-Seldas N, Carreras J, Sanz A, Lebrero-Fernández C, Menéndez C, Vandenberg A, Fernández-Ruiz B et al. ( 2019 ) . Oncogenic Rag GTPase signalling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR . Nature Metabolism vol. 1 , ( 8 ) 775 - 789 .
Okosun J, Bödör C, Batlevi C, Nagy N, Michot J, Schneider T, Alizadeh H, Simon Z et al. ( 2019 ) . EZH2 GAIN‐OF‐FUNCTION MUTATIONS ARE NOT ASSOCIATED WITH MORE FAVORABLE PROGNOSIS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL): A PRELIMINARY ANALYSIS ON 590 PATIENTS . Hematological Oncology vol. 37 , 192 - 193 .
Korfi K, Araf S, Bewicke¿Copley F, Kumar E, Cummin T, Ashton¿Key M, Barrans S, Van Hoppe S et al. ( 2019 ) . LONGITUDINAL ANALYSES OF DIAGNOSTIC‐RELAPSE BIOPSIES OF DIFFUSE LARGE B CELL LYMPHOMA SUGGEST THAT RELAPSE IS MEDIATED BY DISTINCT MECHANISMS IN ABC AND GCB LYMPHOMA . Hematological Oncology vol. 37 , 142 - 143 .
Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al. ( 2019 ) . Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma (Leukemia, (2018), 32, 5, (1261-1265), 10.1038/s41375-018-0043-y) . Leukemia vol. 33 , ( 6 )
Kumar E, Korfi K, Bewicke-Copley F, Witzig T, Leukam M, Ansell S, Scott J, Rallis K et al. ( 2019 ) . MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA . HemaSphere vol. 3 ,
Rio-Machin A, Vulliamy T, Hug N, Caceres JF, Fitzgibbon J, Dokal I ( 2019 ) . PF213 THE GENETIC LANDSCAPE OF FAMILIAL MDS/AML; RECURRING MUTATIONS IN THE RNA HELICASE DHX34 LEADING TO DEFECTS IN NONSENSE-MEDIATED RNA DECAY . HemaSphere vol. 3 , ( S1 )
Kumar E, Korfi K, Bewicke-Copley F, Witzig T, Leukam M, Ansell S, Scott J, Rallis K et al. ( 2019 ) . PF513 MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA . HemaSphere vol. 3 , ( S1 )
Bödör C, Batlevi C, Nagy N, Michot J-M, Schneider T, Alizadeh H, Simon Z, Vose J et al. ( 2019 ) . PS1247 EZH2 GAIN-OF-FUNCTION MUTATIONS ARE NOT ASSOCIATED WITH MORE FAVORABLE PROGNOSIS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A PRELIMINARY ANALYSIS ON 590 PATIENTS . HemaSphere vol. 3 , ( S1 ) 568 - 569 .
Heward J, Koniali L, D¿Avola A, Close K, Yeomans A, Johnson P, Okosun J, Neve R et al. ( 2019 ) . S844 KDM5 INHIBITION OFFERS A NOVEL THERAPEUTIC STRATEGY FOR THE TREATMENT OF KMT2D MUTANT LYMPHOMAS . HemaSphere vol. 3 , ( S1 ) 376 - 377 .
Araf S, Wang J, Ashton-Key M, Korfi K, Di Bella D, Rio-Machin A, Odabashian M, Foria V et al. ( 2019 ) . Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant . Haematologica vol. 104 , ( 4 ) e174 - e177 .
Merron B, Kazmi-Stokes S, Cummin T, Barrans S, Araf S, Korfi K, Pascua LDL, Caddy J et al. ( 2019 ) . Precision medicine for patients with lymphoma; the Bloodwise Precision Medicine for Aggressive Lymphomas (PMAL) consortium . Clinical Medicine vol. 19 , ( Suppl 2 ) 100 - 101 .
Jakobsen JS, Laursen LG, Schuster MB, Pundhir S, Schoof E, Ge Y, D'Altri T, Vitting-Seerup K et al. ( 2019 ) . Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML . Science Advances vol. 5 , ( 7 )
Brown AL, Armstrong M, Lawrence D, Wang P, Arts P, Duployez N, Churpek J, Tawana K et al. ( 2018 ) . Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB . Blood vol. 132 , ( Supplement 1 ) 5241 - 5241 .
DOKAL I, TUMMALA H, VULLIAMY T ( 2018 ) . homozygous OB-fold variants in telomere protein TPP1 are associated with dyskeratosis congenita-like phenotypes . Blood vol. 132 , 1349 - 1353 .
Casado P, Wilkes EH, Miraki-Moud F, Hadi MM, Rio-Machin A, Rajeeve V, Pike R, Iqbal S et al. ( 2018 ) . Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells . Leukemia vol. 32 , ( 8 ) 1818 - 1822 .
Okosun J, Kridel R, Fitzgibbon J ( 2018 ) . Rituximab as a first step in tackling transformation . The Lancet Haematology vol. 5 , ( 8 ) e326 - e327 .
Heward JA, Kumar EA, Korfi K, Okosun J, Fitzgibbon J ( 2018 ) . Precision medicine and lymphoma . Curr Opin Hematol vol. 25 , ( 4 ) 329 - 334 .
Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al. ( 2018 ) . Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma . Leukemia vol. 32 , ( 5 ) 1258 - 1263 .
Al Seraihi AF, Rio-Machin A, Tawana K, Bödör C, Wang J, Nagano A, Heward JA, Iqbal S et al. ( 2018 ) . GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML . Leukemia vol. 32 , ( 11 ) 2502 - 2507 .
Araf S, Okosun J, Fitzgibbon J ( 2018 ) . Predicting early relapse in follicular lymphoma: have we turned a corner? . The Lancet Oncology vol. 19 , ( 4 ) 441 - 442 .
Casado P, Wilkes EH, Miraki-Moud F, Hadi MM, Rio-Machin A, Rajeeve V, Pike R, Iqbal S et al. ( 2017 ) . Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells . Leukemia
Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward JA et al. ( 2017 ) . Genomic Profiling Reveals Spatial Intra-Tumor Heterogeneity in Follicular Lymphoma . BLOOD . vol. 130 ,
Araf S, Korfi K, Nagano A, Cummin TEC, Bentley M, Thorner AR, Ashton-Key M, Calaminici M et al. ( 2017 ) . Longitudinal Analyses of the Genomic, Transcriptomic, and T Cell Repertoire in Diffuse Large B Cell Lymphoma Demonstrates Changes in Signaling and Immune Recognition at Relapse . BLOOD . vol. 130 ,
Gascoyne RD, Nadel B, Pasqualucci L, Fitzgibbon J, Payton JE, Melnick A, Weigert O, Tarte K et al. ( 2017 ) . Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015 . Hematological Oncology vol. 35 , ( 4 ) 397 - 407 .
Horton SJ, Giotopoulos G, Yun H, Vohra S, Sheppard O, Bashford-Rogers R, Rashid M, Clipson A et al. ( 2017 ) . Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors . Nature Cell Biology . vol. 19 , 1093 - 1104 .
Rio-Machin A, Gómez-López G, Muñoz J, Garcia-Martinez F, Maiques-Diaz A, Alvarez S, Salgado RN, Shrestha M et al. ( 2017 ) . The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia . Leukemia vol. 31 , ( 9 ) 2000 - 2005 .
Tawana K, Wang J, Király PA, Kállay K, Benyó G, Zombori M, Csomor J, Al Seraihi A et al. ( 2017 ) . Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree . European Journal of Human Genetics vol. 25 , ( 8 ) 1020 - 1024 .
Cummin TE, Araf S, Du M, Barrans S, Bentley MA, Clipson A, Wang M, Ahmed S et al. ( 2017 ) . PROGNOSTIC SIGNIFICANCE AND CORRELATION TO GENE EXPRESSION PROFILE OF EZH2 MUTATIONS IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL) IN 2 LARGE PROSPECTIVE STUDIES . Hematological Oncology vol. 35 , ( S2 ) 158 - 159 .
Tawana K, Rio-Machin A, Preudhomme C, Fitzgibbon J ( 2017 ) . Familial CEBPA-mutated acute myeloid leukemia . Seminars in Hematology vol. 54 , ( 2 ) 87 - 93 .
Korfi K, Ali S, Heward JA, Fitzgibbon J ( 2017 ) . Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations . Epigenetics vol. 12 , ( 5 ) 370 - 377 .
Casado P, Wilkes E, Hadi MM, Rajeeve V, Miraki-Moud F, Pike R, Del Rio-Machin A, Iqbal S et al. ( 2016 ) . Differentiation Status Revealed By Shotgun Phosphoproteomics Determines Sensitivity of Primary AML Cells to Kinase Inhibitors . Blood . vol. 128 , 840 - 840 .
Fitzgibbon J ( 2016 ) . Genomic Discovery, Prognosis, and Target Therapy Development . Blood vol. 128 , ( 22 )
Rio-Machin A, Gomez-Lopez G, Maiques-Diaz A, Alvarez S, Calasanz MJ, Fitzgibbon J, Cigudosa JC ( 2016 ) . HDAC Inhibitors As Novel Targeted Therapies for NUP98-HOXA9 AML Patients . Blood . vol. 128 , 2685 - 2685 .
Noerenberg D, Mansouri L, Young E, Mareike F, Abdulla M, Asmar F, Gonzalez-Farre B, Anna T et al. ( 2016 ) . NFKBIE Deletions: A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma . BLOOD . vol. 128 ,
Britton DJ, Wilkes E, Casado P, Rajeeve V, Fitzgibbon J, Gribben J, Cutillas PR ( 2016 ) . Proteomic Analysis Directs Effective Drug Selection in Relapsed AML By Quantifying Drug Targets . Blood . vol. 128 , 5265 - 5265 .
Al Seraihi A, Rio-Machin A, Tawana K, Bödör C, Araf S, Heward JA, Smith M, Iqbal S et al. ( 2016 ) . Variable Penetrance Is Linked with Monoallelic Gene Expression in Inherited GATA2-Mutated MDS/AML . Blood . vol. 128 , 3916 - 3916 .
Noerenberg* D, Mansouri* L, Young E, Mareike F, Abdulla M, Asmar F, Gonzalez-Farre B, Anna T et al. ( 2016 ) . ΝFΚΒΙΕ Deletions: A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma . Blood vol. 128 , ( 22 ) 609 - 609 .
Stunnenberg HG, Abrignani S, Adams D, de Almeida M, Altucci L, Amin V, Amit I, Antonarakis SE et al. ( 2016 ) . The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery . Cell vol. 167 , ( 5 ) 1145 - 1149 .
Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V et al. ( 2016 ) . Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma . Blood vol. 128 , ( 23 ) 2666 - 2670 .
Araf S, Korfi K, Rahim T, Davies A, Fitzgibbon J ( 2016 ) . Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine . Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare vol. 16 , ( 10 ) 1093 - 1102 .
Araf S, Fitzgibbon J ( 2016 ) . Pediatric-type FL: Simply different . Blood vol. 128 , ( 8 ) 1030 - 1031 .
Ripperger T, Tawana K, Kratz C, Schlegelberger B, Fitzgibbon J, Steinemann D ( 2016 ) . Clinical utility gene card for: Familial platelet disorder with associated myeloid malignancies . European Journal of Human Genetics vol. 24 , ( 8 ) e1 - e4 .
Tummala H, Walne AJ, Williams M, Bockett N, Collopy L, Cardoso S, Ellison A, Wynn R et al. ( 2016 ) . DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation . American Journal of Human Genetics vol. 99 , ( 1 ) 115 - 124 .
Larrea E, Fernandez-Mercado M, Ceberio I, Guerra-Assunção JA, Okosun J, Fitzgibbon J, Lawrie C ( 2016 ) . 110 Follicular lymphoma cases harbour recurrent mutations in micro-RNA binding sites of genes associated with lymphomagenesis . European Journal of Cancer vol. 61 , s11 - s12 .
Larrea E, Fernandez-Mercado M, Ceberio I, Guerra-Assuncao JA, Okosun J, Fitzgibbon J, Lawrie C ( 2016 ) . Follicular lymphoma cases harbour recurrent mutations in microRNA binding sites of genes associated with lymphomagenesis . EUROPEAN JOURNAL OF CANCER . vol. 61 , S11 - S12 .
GROSE RP, Dawkins JBN, Wang J, maniati, heward, koniali, kocher, martin et al. ( 2016 ) . Reduced expression of histone methyltransferases KMT2C and KMT2D correlates with improved outcome in pancreatic ductal adenocarcinoma . Cancer Research
Araf S, Wang J, Pangault C, Kotsiou E, Hoxha E, Iqbal S, Davies J, Johnson P et al. ( 2016 ) . GENOMIC PROFILING REVEALS SPATIAL HETEROGENEITY IN FOLLICULAR LYMPHOMA: IMPLICATIONS FOR PRECISION MEDICINE . HAEMATOLOGICA . vol. 101 , 270 - 270 .
Britton D, Casado P, Rajeeve V, Wilkes E, Smith R, Fitzgibbon J, Gribben J, Cutillas P ( 2016 ) . PROTEOMIC ANALYSIS OF RELAPSE AML IDENTIFIES OPPORTUNITIES FOR THERAPEUTIC INTERVENTION IN INDIVIDUAL PATIENTS . HAEMATOLOGICA . vol. 101 , 373 - 373 .
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al. ( 2016 ) . Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma (vol 48, pg 183, 2016) . NATURE GENETICS vol. 48 , ( 6 ) 700 - 700 .
Rio-Machin A, Cardoso S, Tawana K, Wang J, Chelala C, Plagnol V, Wallis Y, Ryan G et al. ( 2016 ) . WHOLE EXOME SEQUENCING REVEALS NOVEL CANDIDATE GENES IN FAMILIAL MDS/AML . HAEMATOLOGICA . vol. 101 , 205 - 206 .
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Seraihi AFA et al. ( 2016 ) . Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma . Nat Genet vol. 48 , ( 6 ) 700 - 700 .
DOKAL I ( 2016 ) . Germline heterozygous DDX41 vriants in a subset of familial myelodysplasia and acute myeloid leukaemia . Leukemia
Okosun J, Montoto S, Fitzgibbon J ( 2016 ) . The routes for transformation of follicular lymphoma . Current Opinion in Hematology vol. 23 , ( 4 ) 1 - 1 .
Kotsiou E, Okosun J, Besley C, Iqbal S, Matthews J, Fitzgibbon J, Gribben J, DAVIES JK ( 2016 ) . TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses . Blood vol. 128 , ( 1 ) 72 - 81 .
Strefford JC, Fitzgibbon J, Rose-Zerilli MJJ, Bödör C ( 2016 ) . The genetics of mature B-cell malignancies . The Genetic Basis of Haematological Cancers ,
Tawana K, Fitzgibbon J ( 2016 ) . Inherited DDX41 mutations: 11 genes and counting . Blood vol. 127 , ( 8 ) 960 - 961 .
Klapper W, Klein U, De Silva NS, Zha S, Crowe JL, Dai B, Weilemann A, Okosun J et al. ( 2016 ) . 5. Follicular lymphoma . Malignant Lymphomas ,
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al. ( 2016 ) . Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma . Nature Genetics vol. 48 , ( 2 ) 183 - 188 .
Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, De Wit TD, Eichinger S et al. ( 2016 ) . The european hematology association roadmap for european hematology research: A consensus document . Haematologica vol. 101 , ( 2 ) 115 - 208 .
Araf S, Okosun J, Koniali L, Fitzgibbon J, Heward J ( 2016 ) . Epigenetic dysregulation in follicular lymphoma . Epigenomics vol. 8 , ( 1 ) 77 - 84 .
Okosun J, Fitzgibbon J ( 2016 ) . Follicular lymphoma . Malignant Lymphomas: Biology and Molecular Pathogenesis ,
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al. ( 2015 ) . Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma . Nature Genetics .
Tawana K, Wang J, Renneville A, Bödör C, Hills R, Loveday C, Savic A, Van Delft FW et al. ( 2015 ) . Disease evolution and outcomes in familial AML with germline CEBPA mutations . Blood vol. 126 , ( 10 ) 1214 - 1223 .
Carlotti E, Wrench D, Rosignoli G, Marzec J, Sangaralingam A, Hazanov L, Michaeli M, Hallam S et al. ( 2015 ) . High throughput sequencing analysis of the immunoglobulin heavy chain gene from flow-sorted B cell sub-populations define the dynamics of follicular lymphoma clonal evolution . PLoS ONE vol. 10 , ( 9 )
Tawana K, Wang J, Kiraly PA, Kallay K, Benyo G, Krivan G, Csomor J, Fitzgibbon J et al. ( 2015 ) . CONVERGENCE OF SOMATIC MUTATIONS WITHIN THE JAK-STAT SIGNALLING PATHWAY IN A NOVEL RUNX1-MUTATED PEDIGREE . HAEMATOLOGICA . vol. 100 , 9 - 10 .
Koniali L, Heward J, Loveday C, Wilkins L, Ishfaq M, Wang J, Okosun J, Packham G et al. ( 2015 ) . KDM5 INHIBITION LEADS TO INCREASED H3K4ME3 LEVELS AND CELL DEATH IN GERMINAL CENTRE LYMPHOMA CELL LINES INDEPENDENT OF MLL2 MUTATION STATUS . HAEMATOLOGICA . vol. 100 , 104 - 104 .
Noerenberg D, Frick M, Couronne L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J et al. ( 2015 ) . NFKBIE MUTATIONS OCCUR IN 15% OF GCB DLBCL AND IN VARIOUS OTHER LYMPHOID MALIGNANCIES . HAEMATOLOGICA . vol. 100 , 549 - 549 .
Kotsiou E, Okosun J, Clear AJ, Iqbal S, Fitzgibbon J, Gribben JG, Davies JK ( 2014 ) . TNFRSF14 aberrations in Follicular Lymphoma B Cells Result in Increased Alloresponses in Vitro and in Vivo . Blood . vol. 124 , 2426 - 2426 .
Haider S, Wang J, Nagano A, Desai A, Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T et al. ( 2014 ) . A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma . Genome Medicine vol. 6 , ( 12 )
Rohatiner AZS, Smith ML, Spinelli O, Rambaldi A, Bassan R, di Bona E, Rodeghiero F, Raimondi R et al. ( 2014 ) . Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-up . British Journal of Haematology vol. 167 , ( 5 ) 724 - 726 .
Okosun J, Packham G, Fitzgibbon J ( 2014 ) . Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies . Expert Opin Investig Drugs vol. 23 , ( 10 ) 1321 - 1332 .
Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Zhang W et al. ( 2014 ) . Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma . BLOOD vol. 123 , ( 11 ) 1681 - 1690 .
Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D et al. ( 2014 ) . Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma . Nature Genetics vol. 46 , ( 2 ) 176 - 181 .
Okosun J, Bödör C, Wang J, Araf S, Yang C-Y, Pan C, Boller S, Cittaro D et al. ( 2014 ) . Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma . Nat Genet vol. 46 , ( 2 ) 176 - 181 .
Tawana K, Renneville A, Wang J, Georgiades P, Thomas X, Mialou V, Savic A, Van Delft FW et al. ( 2013 ) . Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing . Blood . vol. 122 , 740 - 740 .
Popov N, Maniati E, Marzec J, Okosun J, Scott R, Kranz A, Stewart F, Chelala C et al. ( 2013 ) . Investigating The Role Of MLL2 (Mll4) In B Cell Development . Blood . vol. 122 , 343 - 343 .
Mutsaers PGNJ, van de Loosdrecht AA, Tawana K, Bödör C, Fitzgibbon J, Menko FH ( 2013 ) . Highly variable clinical manifestations in a large family with a novel GATA2 mutation . Leukemia vol. 27 , ( 11 ) 2247 - 2248 .
Bödör C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K, Marzec J, Araf S et al. ( 2013 ) . EZH2 mutations are frequent and represent an early event in follicular lymphoma . Blood vol. 122 , ( 18 ) 3165 - 3168 .
Okosun J, Bödör C, Wang J, Araf S, Chelala C, Fitzgibbon J ( 2013 ) . Genomic analysis reveals epigenetic ‘addiction’ underpinning follicular lymphoma and its transformation – a rationale for targeted epigenetic therapies . Clinical Epigenetics vol. 5 , ( Suppl 1 ) s10 - s10 .
Gertner-Dardenne J, Fauriat C, Orlanducci F, Thibult M-L, Pastor S, Fitzgibbon J, Bouabdallah R, Xerri L et al. ( 2013 ) . The co-receptor BTLA negatively regulates human V gamma 9V delta 2 T-cell proliferation: a potential way of immune escape for lymphoma cells . BLOOD vol. 122 , ( 6 ) 922 - 931 .
Green CL, Tawana K, Hills RK, Bödör C, Fitzgibbon J, Inglott S, Ancliff P, Burnett AK et al. ( 2013 ) . GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations . Br J Haematol vol. 161 , ( 5 ) 701 - 705 .
Okosun J, Clear A, Iqbal S, Matthews J, Gribben J, Fitzgibbon J, Davies J ( 2013 ) . TNFRSF14 aberrations are associated with death from acute GvHD after reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation for follicular lymphoma . BONE MARROW TRANSPLANTATION . vol. 48 , S169 - S169 .
Robbez-Masson LJ, Bödör C, Jones JL, Hurst HC, Fitzgibbon J, Hart IR, Grose RP ( 2013 ) . Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing . PLoS One vol. 8 , ( 11 )
Bouska A, McKeithan T, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Liu Z et al. ( 2012 ) . Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma . BLOOD . vol. 120 ,
Bo¿odo¿or C, Vera G, Kohlmann A, Tan K, Okosun J, Popov N, Araf S, Marzec J et al. ( 2012 ) . High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy . Blood vol. 120 , ( 21 ) 545 - 545 .
Okosun J, Boedoer C, Wang J, Araf S, Marzec J, Iqbal S, Matthews J, Calaminici M et al. ( 2012 ) . Whole Genome Sequencing in Sequential Biopsies Reveals the Genetic Evolution of Follicular Lymphoma to Transformed Follicular Lymphoma . BLOOD . vol. 120 ,
Delage B, Luong P, Maharaj L, O'Riain C, Syed N, Crook T, Hatzimichael E, Papoudou-Bai A et al. ( 2012 ) . Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis . Cell Death Dis vol. 3 ,
Quintana-Bustamante O, Smith SL-L, Griessinger E, Reyal Y, Vargaftig J, Lister TA, Fitzgibbon J, Bonnet D ( 2012 ) . Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis . LEUKEMIA vol. 26 , ( 7 ) 1537 - 1546 .
Bödör C, Renneville A, Smith M, Charazac A, Iqbal S, Etancelin P, Cavenagh J, Barnett MJ et al. ( 2012 ) . Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival . Haematologica vol. 97 , ( 6 ) 890 - 894 .
Adams D, Altucci L, Antonarakis SE, Ballesteros J, Beck S, Bird A, Bock C, Boehm B et al. ( 2012 ) . BLUEPRINT to decode the epigenetic signature written in blood . NATURE BIOTECHNOLOGY vol. 30 , ( 3 ) 224 - 226 .
Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, Chan W-C, Braziel RM et al. ( 2011 ) . MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype . Blood vol. 118 , ( 20 ) 5550 - 5558 .
Okosun J, Fitzgibbon J ( 2011 ) . It's a targeted world in non-Hodgkin's lymphoma . Br J Nurs vol. 20 , ( 17 )
Okosun J, Fitzgibbon J ( 2011 ) . It's a targeted world in non-Hodgkin's lymphoma . British Journal of Nursing vol. 20 , ( 17 SUPPL. )
Fitzgibbon J ( 2011 ) . A Molecular Portrait of Follicular Lymphoma . EUROPEAN JOURNAL OF CANCER . vol. 47 , S33 - S33 .
Stevens J, Waters R, Sieniawska C, Kassam S, Montoto S, Fitzgibbon J, Rohatiner A, Lister A et al. ( 2011 ) . Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies . Br J Haematol vol. 154 , ( 4 ) 448 - 456 .
Montoto S, Fitzgibbon J ( 2011 ) . Transformation of indolent B-cell lymphomas . J Clin Oncol vol. 29 , ( 14 ) 1827 - 1834 .
Szlosarek PW, Luong F, Clear A, Taussig D, Joel S, Calaminici M, Debernardi S, Fitzgibbon J et al. ( 2011 ) . Abstract 4067: Pegylated arginine deiminase (ADI-PEG20) as a potential novel therapy for argininosuccinate synthetase-deficient acute myeloid leukemia . 4067 - 4067 .
Szlosarek PW, Luong F, Clear A, Taussig D, Joel S, Calaminici M, Debernardi S, Fitzgibbon J et al. ( 2011 ) . Pegylated arginine deiminase (ADI-PEG20) as a potential novel therapy for argininosuccinate synthetase-deficient acute myeloid leukemia . CANCER RESEARCH vol. 71 ,
Bödör C, O'Riain C, Wrench D, Matthews J, Iyengar S, Tayyib H, Calaminici M, Clear A et al. ( 2011 ) . EZH2 Y641 mutations in follicular lymphoma . Leukemia vol. 25 , ( 4 ) 726 - 729 .
Wrench D, Leighton P, Skibola CF, Conde L, Cazier J-B, Matthews J, Iqbal S, Carlotti E et al. ( 2011 ) . SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma . Blood vol. 117 , ( 11 ) 3147 - 3150 .
Langabeer SE, Owen CJ, McCarron SL, Fitzgibbon J, Smith OP, O'Marcaigh A, Browne P ( 2010 ) . A novel RUNX1 mutation in a kindred with familial platelet disorder with propensity to acute myeloid leukaemia: male predominance of affected individuals . Eur J Haematol vol. 85 , ( 6 ) 552 - 553 .
Wrench D, Sangaralingam A, Tayyib H, Kang MK, Riain C, Gupta M, Carlotti E, Bodor C et al. ( 2010 ) . TNFRSF14 and EZH2 Mutations, Chr2p Gain and Copy Number Changes Targeting Genes Whose Proteins Interact with the Microenvironment In Transformed Follicular Lymphoma . BLOOD . vol. 116 , 349 - 349 .
Wrench D, Montoto S, Fitzgibbon J ( 2010 ) . Molecular signatures in the diagnosis and management of follicular lymphoma . Curr Opin Hematol vol. 17 , ( 4 ) 333 - 340 .
Ghazaly E, Smith P, Quentmeier H, Drexler H, Iqbal S, Taussig D, Young B, Lister A et al. ( 2010 ) . ACCUMULATION OF 2-HYDROXYGLUTARATE (2-HG) IN NORMAL KARYOTYPE AML PATIENTS WITH IDH1 MUTATION . HAEMATOLOGICA . vol. 95 , 20 - 20 .
O'Riain C, Smith P, Clear A, Wrench D, Gupta M, Bodor C, Matolcsy A, Calaminici M et al. ( 2010 ) . EZH2 MUTATION IN FOLLICULAR LYMPHOMA . HAEMATOLOGICA . vol. 95 , 167 - 167 .
Wrench J, Skibola C, Matthews J, Cazier JB, Iqbal S, Carlotti E, Calaminici M, Davies A et al. ( 2010 ) . SNP RS6457327 ON CHROMOSOME 6P PREDICTS TRANSFORMATION OF FOLLICULAR LYMPHOMA . HAEMATOLOGICA . vol. 95 , 170 - 171 .
Ghazaly E, Smith P, Quentmeier H, Drexler H, Iqbal S, Taussig D, Young B, Lister A et al. ( 2010 ) . ACCUMULATION OF 2-HYDROXYGLUTARATE (2-HG) IN NORMAL KARYOTYPE AML PATIENTS WITH IDH1 MUTATION . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 95 , 20 - 20 .
O' Riain C, Smith P, Clear A, Wrench D, Gupta M, Bodor C, Matolcsy A, Calaminici M et al. ( 2010 ) . EZH2 MUTATION IN FOLLICULAR LYMPHOMA . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 95 , 167 - 167 .
Wrench J, Skibola C, Matthews J, Cazier JB, Iqbal S, Carlotti E, Calaminici M, Davies A et al. ( 2010 ) . SNP RS6457327 ON CHROMOSOME 6P PREDICTS TRANSFORMATION OF FOLLICULAR LYMPHOMA . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 95 , 170 - 171 .
Szlosarek PW, Delage B, O'Riain C, Hatzimichael E, Crook T, Calaminici M, Gribben JG, Lemoine N et al. ( 2010 ) . Effect of inactivation of argininosuccinate synthetase on sensitivity of lymphomas to caspase-dependent apoptosis following treatment with arginine deiminase . Journal of Clinical Oncology vol. 28 , ( 15_suppl ) 8093 - 8093 .
Langabeer SE, Owen CJ, McCarron SL, Fitzgibbon J, O'Marcaigh A, Browne P ( 2010 ) . A novel RUNX1 mutation in an Irish kindred with familial platelet disorder with propensity to acute myeloid leukaemia . BRITISH JOURNAL OF HAEMATOLOGY . vol. 149 , 73 - 73 .
Owen CJ, Fitzgibbon J ( 2010 ) . The Genetics of Acute Myeloid Leukemias . Molecular Hematology: Third Edition ,
Owen C, Fitzgibbon J, Paschka P ( 2010 ) . The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia . HEMATOL ONCOL vol. 28 , ( 1 ) 13 - 19 .
O'Riain C, Calaminici M, Clear A, Braziel RM, Gascoyne RD, Rosenwald A, Campo E, Smeland EB et al. ( 2010 ) . DNA Methylation and Polycomb Repression in Follicular Lymphoma . MODERN PATHOLOGY . vol. 23 , 315A - 315A .
O'Riain C, O'Shea DM, Yang Y, Le Dieu R, Gribben JG, Summers K, Yeboah-Afari J, Bhaw-Rosun L et al. ( 2009 ) . Array-based DNA methylation profiling in follicular lymphoma . Leukemia vol. 23 , ( 10 ) 1858 - 1866 .
Fitzgibbon J ( 2009 ) . The Molecular Pathogenesis of Follicular Lymphoma . JOURNAL OF MEDICAL GENETICS . vol. 46 , S24 - S24 .
Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC et al. ( 2009 ) . Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations . BLOOD vol. 114 , ( 4 ) 826 - 834 .
Oke A, Pearce D, Wilkinson RW, Crafter C, Odedra R, Cavenagh J, Fitzgibbon J, Lister AT et al. ( 2009 ) . AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo . CANCER RES vol. 69 , ( 10 ) 4150 - 4158 .
Carlotti E, Wrench D, Matthews J, Iqbal S, Davies A, Norton A, Hart J, Lai R et al. ( 2009 ) . Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone . Blood vol. 113 , ( 15 ) 3553 - 3557 .
O'Shea D, O'Riain C, Gupta M, Waters R, Yang Y, Wrench D, Gribben J, Rosenwald A et al. ( 2009 ) . Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation . Blood vol. 113 , ( 10 ) 2298 - 2301 .
Fitzgibbon J, Gale R, Hills R, Virappane P, Burnett A, Lister TA, Linch D ( 2009 ) . Comparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia REPLY . J CLIN ONCOL vol. 27 , ( 3 ) 474 - 476 .
Wrench D, Waters R, Carlotti E, Iqbal S, Matthews J, Calaminici M, Gribben J, Lister TA et al. ( 2009 ) . Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma . HAEMATOL-HEMATOL J vol. 94 , ( 1 ) 148 - 150 .
Owen CJ, Toze CL, Koochin A, Forrest DL, Smith CA, Stevens JM, Jackson SC, Poon M-C et al. ( 2008 ) . Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy . Blood vol. 112 , ( 12 ) 4639 - 4645 .
Virappane P, Gale R, Hills R, Kakkas I, Summers K, Stevens J, Allen C, Green C et al. ( 2008 ) . Mutation of the Wilms' Tumor 1 Gene Is a Poor Prognostic Factor Associated With Chemotherapy Resistance in Normal Karyotype Acute Myeloid Leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party . JOURNAL OF CLINICAL ONCOLOGY . vol. 26 , 5429 - 5435 .
Deffenbacher KE, Wright G, Iqbal J, Geng HM, O'Shea D, Lister TA, Fitzgibbon J, Fu K et al. ( 2008 ) . Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma . BLOOD . vol. 112 , 714 - 714 .
Deffenbacher KE, Wright G, Iqbal J, Geng H, O¿Shea D, Lister TA, Fitzgibbon J, Fu K et al. ( 2008 ) . Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma . Blood vol. 112 , ( 11 ) 2049 - 2049 .
Yang YW, Wrench DJ, Lister TA, Fitzgibbon J ( 2008 ) . Recurrent Chromosomal Intermingling Interactions at the BCL2 Locus in T(14;18) +Ve and -Ve Cell Lines . BLOOD . vol. 112 , 713 - 713 .
Yang Y, Wrench DJ, Lister TA, Fitzgibbon J ( 2008 ) . Recurrent Chromosomal Intermingling Interactions at the BCL2 Locus in T(14;18) +Ve and −Ve Cell Lines . Blood vol. 112 , ( 11 ) 2048 - 2048 .
Quintana-Bustamante O, Smith SLL, Fitzgibbon J, Bonnet D ( 2008 ) . Role of Different C/EBP alpha Mutations in AML Transformation . BLOOD . vol. 112 , 484 - 484 .
Quintana-Bustamante O, Smith SL-L, Fitzgibbon J, Bonnet D ( 2008 ) . Role of Different C/EBPα Mutations in AML Transformation . Blood vol. 112 , ( 11 ) 1343 - 1343 .
O'Shea D, O'Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, Gribben J, Rosenwald A et al. ( 2008 ) . The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival . Blood vol. 112 , ( 8 ) 3126 - 3129 .
Raghavan M, Smith L-L, Lillington DM, Chaplin T, Kakkas I, Molloy G, Chelala C, Cazier J-B et al. ( 2008 ) . Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia . Blood vol. 112 , ( 3 ) 814 - 821 .
Stevens JM, Waters R, Sieniawska C, Rohatiner A, Fitzgibbon J, Joel SP, Lister TA ( 2008 ) . ASSOCIATION OF SERUM SELENIUM AT PRESENTATION, PATIENT CHARACTERISTICS AND OUTCOME IN HODGKIN AND FOLLICULAR LYMPHOMA . HAEMATOLOGICA . vol. 93 , 249 - 249 .
Stevens JM, Juliger S, Summers K, Fitzgibbon J, Lister TA, Joel SP ( 2008 ) . METHYLSELENINIC ACID DEMONSTRATES ANTI-LEUKAEMIC ACTIVITY AND SENSITISES AML CELLS TO THE EFFECTS OF CYTOTOXIC AGENTS BY INITIATING THE UNFOLDED PROTEIN RESPONSE . HAEMATOLOGICA . vol. 93 , 115 - 116 .
Wrench D, Waters R, Matthews J, Calaminici M, Carlotti E, Iqbal S, Gribben J, Lister A et al. ( 2008 ) . MDM2 309 and TP53 ARG72PRO SNP genotypes do not predict clinical outcome of follicular lymphoma . ANNALS OF ONCOLOGY . vol. 19 , 178 - 178 .
Stevens JM, Juliger S, Summers K, Fitzgibbon J, Lister TA, Joel SP ( 2008 ) . METHYLSELENINIC ACID DEMONSTRATES ANTI-LEUKAEMIC ACTIVITY AND SENSITISES AML CELLS TO THE EFFECTS OF CYTOTOXIC AGENTS BY INITIATING THE UNFOLDED PROTEIN RESPONSE . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 93 , 115 - 116 .
O'Riain C, O'Shea D, Yang Y, Gribben J, Afari J, Mein CA, Crook T, Smith P et al. ( 2008 ) . Methylation profiling in 158 cases of previously untreated follicular lymphoma (FL) . ANNALS OF ONCOLOGY . vol. 19 , 101 - 101 .
O'Shea D, O'Riain C, MacDougall F, Gribben J, Young BD, Rosenwald A, Rimsza L, Roberts R et al. ( 2008 ) . SNP array genotyping in 182 diagnostic follicular lymphoma cases identifies sites of AUPD associated with overall survival and risk of transformation . ANNALS OF ONCOLOGY . vol. 19 , 111 - 111 .
Owen C, Virappane P, Alikian M, Stasevich I, Summers K, Lillington D, Bonnet D, Burnett A et al. ( 2008 ) . WTX is rarely mutated in acute myeloid leukemia . HAEMATOL-HEMATOL J vol. 93 , ( 6 ) 947 - 948 .
Owen CJ, Toze CJ, Forrest DL, Macheta A, Smith CA, Barnett MJ, Yin JAL, Lister TA et al. ( 2008 ) . Should patients with myelodysplasia and/or acute myeloid leukemia (MDS/AML) be screened for inherited runx1 mutations prior to sibling donor allografting? . ANN HEMATOL vol. 87 , S11 - S11 .
Owen C, Barnett M, Fitzgibbon J ( 2008 ) . Familial myelodysplasia and acute myeloid leukaemia--a review . Br J Haematol vol. 140 , ( 2 ) 123 - 132 .
Carlotti E, Wrench D, Iqbal S, O¿Shea D, Davies A, Virappane P, Hart J, Lai R et al. ( 2007 ) . Determining the Mechanism of Transformation of Follicular Lymphoma into Diffuse Large B Cell Lymphoma . Blood vol. 110 , ( 11 ) 181 - 181 .
Carlotti E, Wrench D, Iqbal S, O'Shea D, Davies A, Virappane P, Hart J, Lai R et al. ( 2007 ) . Determining the mechanism of transformation of follicular lymphoma into diffuse large B cell lymphoma . BLOOD . vol. 110 , 61A - 61A .
Virappane P, Gale RE, Hills R, Kakkas I, Summers K, Stevens J, Green C, Allen C et al. ( 2007 ) . Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemoresistance in normal karyotype acute myeloid leukemia . BLOOD . vol. 110 , 113A - 113A .
Virappane P, Gale RE, Hills R, Kakkas I, Summers K, Stevens J, Green C, Allen C et al. ( 2007 ) . Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated with Chemoresistance in Normal Karyotype Acute Myeloid Leukemia . Blood vol. 110 , ( 11 ) 361 - 361 .
Owen CJ, Yin JAL, Toze CJ, Forrest DL, Macheta A, Smith CA, Barnett MJ, Lister TA et al. ( 2007 ) . Should patients with myelodysplasia and/or acute myeloid leukemia (MDS/AML) be screened for inherited RUNX1 mutations prior to sibling donor allografting? . BLOOD . vol. 110 , 336B - 336B .
Jüliger S, Goenaga-Infante H, Lister TA, Fitzgibbon J, Joel SP ( 2007 ) . Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species . Cancer Res vol. 67 , ( 22 ) 10984 - 10992 .
Fitzgibbon J, Iqbal S, Davies A, O'shea D, Carlotti E, Chaplin T, Matthews J, Raghavan M et al. ( 2007 ) . Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma . Leukemia vol. 21 , ( 7 ) 1514 - 1520 .
Owen C, Stevens J, Amess J, Chaplin T, Cavenagh J, Lillington D, Young BD, Lister TA et al. ( 2007 ) . Familial myelodysplasia with monosomy 7 . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 92 , 234 - 234 .
O'Shea D, Iqbal S, Carlotti E, Davies A, Chaplin T, Matthews J, Manoj M, Norton A et al. ( 2007 ) . SNP array profiling of follicular lymphoma reveals novel regions of acquired UPD . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 92 , 62 - 62 .
Kakkas I, Summers K, Fleischmann C, Virappane P, Lister TA, Fitzgibbon J ( 2007 ) . Simultaneous detection of FLT3, NPM1 and WT1 mutations using high-resolution capillary electrophoresis . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 92 , 370 - 370 .
Virappane P, Gale RE, Hills RK, Kakkas K, Summers K, Stevens J, Green CL, Allen CG et al. ( 2007 ) . Wilms' tumour 1 mutation in normal karyotype aml . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL . vol. 92 , 19 - 20 .
Raghavan M, Smith LL, Chaplin T, Lillington D, Molloy G, Kakkas I, Chelala C, Cazier JB et al. ( 2007 ) . Frequent relapse of acute myeloid leukaemia by mitotic recombination . BRITISH JOURNAL OF HAEMATOLOGY . vol. 137 , 25 - 25 .
Juliger S, Joel SP, Fitzgibbon J, Lister TA ( 2007 ) . Serum selenium at presentation may predict disease outcome in acute myeloid leukaemia (AML) . BRITISH JOURNAL OF HAEMATOLOGY . vol. 137 , 65 - 65 .
Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J et al. ( 2007 ) . Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms . BRIT J HAEMATOL vol. 136 , ( 2 ) 286 - 293 .
Summers K, Stevens J, Kakkas I, Smith M, Smith LL, MacDougall F, Cavenagh J, Bonnet D et al. ( 2007 ) . Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML [1] . Leukemia vol. 21 , ( 3 ) 550 - 551 .
O'Shea D, Iqbal S, Carlotti E, Davies A, Chaplin T, Matthews J, Raghavan M, Norton A et al. ( 2006 ) . aUPD in the clonal evolution of follicular lymphoma . BLOOD . vol. 108 , 585A - 585A .
Last K, Maharaj L, Perry J, Strauss S, Fitzgibbon J, Lister TA, Joel S ( 2006 ) . The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours . ANN ONCOL vol. 17 , ( 5 ) 773 - 779 .
Zhang LY, Smith ML, Schultheis B, Fitzgibbon J, Lister TA, Melo JV, Cross NCP, Cavenagh JD ( 2006 ) . A novel K5091 mutation of KIT identified in familial mastocytosis - in vitro and in vivo responsiveness to imatinib therapy . LEUKEMIA RES vol. 30 , ( 4 ) 373 - 378 .
Smith LL, Pearce D, Smith ML, Jenner M, Lister TA, Bonnet D, Goff L, Fitzgibbon J ( 2006 ) . Development of a quantitative real-time polymerase chain reaction method for monitoring CEBPA mutations in normal karyotype acute myeloid leukaemia . BRIT J HAEMATOL vol. 133 , ( 1 ) 103 - 105 .
Juliger S, Goenaga-Infante H, Fitzgibbon J, Lister AT, Joel SP ( 2005 ) . Methylseleninic Acid Results in Rapid Changes in Intracellular Selenium Species and Sensitises Human Lymphoma Cells to Doxorubicin . Blood vol. 106 , ( 11 ) 1768 - 1768 .
Juliger S, Goenaga-Infante H, Fitzgibbon J, Lister AT, Joel SP ( 2005 ) . Methylseleninic acid results in rapid changes in intracellular selenium species and sensitises human lymphoma cells to doxorubicin . BLOOD . vol. 106 , 503A - 503A .
Joel SP, Oke A, Foot N, Keen N, Bonnet D, Lister TA, Fitzgibbon J ( 2005 ) . The activity of the novel aurora kinase B inhibitor AZD1152 in acute myeloid leukaemia cells . BLOOD . vol. 106 , 943A - 943A .
Fitzgibbon J, Smith L-L, Raghavan M, Smith ML, Debernardi S, Skoulakis S, Lillington D, Lister TA et al. ( 2005 ) . Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias . Cancer Res vol. 65 , ( 20 ) 9152 - 9154 .
Davies AJ, Lee AM, Taylor C, Clear AJ, Goff LK, Iqbal S, Cuthbert-Heavens D, Calaminici M et al. ( 2005 ) . A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma . LEUKEMIA vol. 19 , ( 8 ) 1459 - 1465 .
Smith LL, Smith M, Goff L, Jenner M, Lister A, Fitzgibbon J, Bonnett D ( 2005 ) . Development of a quantitative real-time PCR method for monitoring CEBPA mutations in normal karyotype acute myeloid leukaemia patient samples . EXPERIMENTAL HEMATOLOGY . vol. 33 , 73 - 73 .
Davies A, Iqbal S, Fitzgibbon J, Raghavan M, Chaplin T, Norton A, Lister A, Young B ( 2005 ) . Homozygosity mapping by genome-wide SNP analysis of the transformation of follicular lymphoma (FL) to diffuse large B-cell lymphoma (TxDLBCL) . ANNALS OF ONCOLOGY . vol. 16 , 106 - 106 .
Davies A, Arch R, Goff L, Gesk S, Foot N, Rosenwald A, Dyer M, Marinez-Climent J et al. ( 2005 ) . Refinement of the 13q31-32 amplicon in B-cell non-Hodgkin's lymphoma by a simultaneous genomic and transcriptional approach . ANNALS OF ONCOLOGY . vol. 16 , 80 - 80 .
Suraweera N, Meijne E, Moody J, Carvajal-Carmona LG, Yoshida K, Pollard P, Fitzgibbon J, Riches A et al. ( 2005 ) . Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia . Oncogene vol. 24 , ( 22 ) 3678 - 3683 .
Lee A, Davies AJ, Clear A, Calaminici M, Matthews J, Norton A, Wright G, Staudt MLM et al. ( 2005 ) . Tissue microarray is a useful tool in the evaluation of genes implicated in transformation of follicular lymphoma . JOURNAL OF PATHOLOGY . vol. 205 , 11 - 11 .
Smith ML, Arch R, Smith L-L, Bainton N, Neat M, Taylor C, Bonnet D, Cavenagh JD et al. ( 2005 ) . Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3 . Br J Haematol vol. 128 , ( 3 ) 318 - 323 .
Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J ( 2004 ) . Brief report - Mutation of CEBPA in familial acute myeloid leukemia . NEW ENGL J MED vol. 351 , ( 23 ) 2403 - 2407 .
Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J ( 2004 ) . Mutation of CEBPA in familial acute myeloid leukemia . N Engl J Med vol. 351 , ( 23 ) 2403 - 2407 .
Beguin Y, Weber G, Last KW, Rohatiner AZS, Fitzgibbon J, Lister TA ( 2004 ) . Serum selenium in lymphoma [1] (multiple letters) . Journal of Clinical Oncology vol. 22 , ( 16 ) 3429 - 3430 .
Fitzgibbon J, Smith M, Arch R, Smith L-L, Bainton N, Neat M, Bonnet D, Cavenagh J et al. ( 2004 ) . Development of a Human Acute Myeloid Leukaemia Screening Panel and Identification of Novel Gene Mutations . Blood vol. 104 , ( 11 ) 2991 - 2991 .
Fitzgibbon J, Smith M, Arch R, Smith LL, Bainton N, Neat M, Bonnet D, Cavenagh J et al. ( 2004 ) . Development of a human acute myeloid leukaemia screening panel and identification of novel gene mutations . BLOOD . vol. 104 , 817A - 817A .
Ridler C, Smith M, Milne T, Ebrahim F, Macey M, Lister TA, Fitzgibbon J, Cavenagh JD et al. ( 2004 ) . Flow cytometric FLT3 expression in acute leukaemias is of diagnostic value but does not correlate with ITD/D835Y mutation status . BLOOD . vol. 104 , 823A - 823A .
Fitzgibbon J, Smith M, Cavenagh J, Lister TA ( 2004 ) . Mutation of CEBPA in familial acute myeloid leukaemia . BLOOD . vol. 104 , 555A - 555A .
Davies AJ, Lee AM, Taylor C, Clear AJ, Goff LK, Iqbal S, Cuthbert-Heavens D, Calaminici M et al. ( 2004 ) . Sequential Time-Point Mutational Analysis of TP53 in Follicular Lymphoma Undergoing Transformation to Large B-Cell Lymphoma . Blood vol. 104 , ( 11 ) 1361 - 1361 .
Davies AJ, Lee AM, Taylor C, Clear AJ, Goff LK, Iqbal S, Cuthbert-Heavens D, Calaminici M et al. ( 2004 ) . Sequential time-point mutational analysis of TP53 in follicular lymphoma undergoing transformation to large B-cell lymphoma . BLOOD . vol. 104 , 382A - 382A .
Last K, Perry J, Maharaj L, Strauss S, Davies A, Skoulakis S, Fitzgibbon J, Lister A et al. ( 2004 ) . The induction of apoptosis in lymphoma cells by methylseleninic acid and selenodiglutathione . BLOOD . vol. 104 , 686A - 686A .
Lee A, Davies A, Clear A, Calaminici M, Matthews J, Norton A, Wright G, Staudt LM et al. ( 2004 ) . Tissue microarray is a useful tool in the evaluation of genes implicated in transformation of follicular lymphoma . BLOOD . vol. 104 , 624A - 624A .
Last KW, Rohatiner AZS, Fitzgibbon J, Lister TA ( 2004 ) . Serum selenium in lymphoma - In reply . J CLIN ONCOL vol. 22 , ( 16 ) 3430 - 3430 .
Nilsen H, An Q, Fitzgibbon J, Lister A, Lindahl T ( 2004 ) . Complex phenotypes associated with uracil in DNA in mammals . BRITISH JOURNAL OF CANCER . vol. 91 , S71 - S71 .
Iqbal S, Jenner MJR, Summers KE, Davies AJ, Matthews J, Norton AJ, Calaminici M, Rohatiner AZ et al. ( 2004 ) . Reliable detection of clonal IgH/Bcl2 MBR rearrangement in follicular lymphoma: methodology and clinical significance . Br J Haematol vol. 124 , ( 3 ) 325 - 328 .
Goff LK, Iqbal S, Jenner MJ, Summers KE, Matthews J, Norton AJ, Calaminici M, Rohatiner AZS et al. ( 2003 ) . Reliable detection of clonal IgH/Bcl-2 MBR rearrangement in follicular lymphoma: Methodology and clinical significance . BLOOD . vol. 102 , 633A - 633A .
Debernardi S, Van Delft F, Davies A, Lillington D, Smith M, Lister TA, Saha V, Young BD et al. ( 2003 ) . The Wiskott-Aldrich-Syndrome family member 1 (WASF1) gene on 6q21 is down-regulated in specific AML cytogenetic subtypes . BLOOD . vol. 102 , 582A - 582A .
Last KW, Cornelius V, Delves T, Sieniawska C, Fitzgibbon J, Norton A, Amess J, Wilson A et al. ( 2003 ) . Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma . J Clin Oncol vol. 21 , ( 12 ) 2335 - 2341 .
Snaddon J, Smith ML, Neat M, Cambal-Parrales M, Dixon-McIver A, Arch R, Amess JA, Rohatiner AZ et al. ( 2003 ) . Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2 . Genes Chromosomes Cancer vol. 37 , ( 1 ) 72 - 78 .
Smith ML, Snaddon J, Neat M, Cambal-Parrales M, Arch R, Lister TA, Fitzgibbon J ( 2003 ) . Mutation of BRAF is uncommon in AML FAB type M1 and M2 . LEUKEMIA vol. 17 , ( 1 ) 274 - 275 .
Davies A, Rosenwald A, Wright G, Henrickson SE, Hong Z, Fitzgibbon J, Last K, Norton A et al. ( 2002 ) . Gene expression profiling in paired follicular lymphoma samples pre- and post-transformation to large B cell lymphoma . BLOOD . vol. 100 , 315A - 316A .
Jenner M, Summers K, Matthews J, Bradburn M, Dunning A, Wilson G, Lister TA, Fitzgibbon J ( 2002 ) . Genetic risk factor for follicular lymphoma within the MHC region . BLOOD . vol. 100 , 567A - 567A .
Fitzgibbon J, Arch R, Davies A, Snaddon J, Neat M, Foot N, Summers K, Goff L et al. ( 2002 ) . Refinement and evaluation of candidate genes within the 13q amplicon in germinal centre lymphoma . BLOOD . vol. 100 , 189B - 190B .
Jenner MJ, Summers KE, Norton AJ, Amess JA, Arch RS, Young BD, Lister TA, Fitzgibbon J et al. ( 2002 ) . JH probe real-time quantitative polymerase chain reaction assay for Bcl-2/IgH rearrangements . Br J Haematol vol. 118 , ( 2 ) 550 - 558 .
Summers KE, Davies AJ, Matthews J, Jenner MJ, Cornelius V, Amess JA, Norton AJ, Rohatiner AZS et al. ( 2002 ) . The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real-time polymerase chain reaction . Br J Haematol vol. 118 , ( 2 ) 563 - 566 .
Snaddon J, Neat M, Fitzgibbon J, Smith ML, Rohatiner AZ, Lister TA, Amess JA ( 2002 ) . Mutations in the runt homology domain of CBFalpha2 in myeloid malignancies with acquired trisomy 21 . Cancer Genet Cytogenet vol. 136 , ( 2 ) 151 - 152 .
Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J ( 2001 ) . The frequency of the Bcl-2/IgH t(14;18)(q32;q21) rearrangement in normal individuals implications for the monitoring of disease in patients with follicular lymphoma . LEUKEMIA vol. 15 , ( 12 ) 2024 - 2024 .
Jenner MJ, Summers KE, Norton AJ, Amess JA, Arch RS, Young BD, Lister TA, Fitzgibbon J et al. ( 2001 ) . A universal strategy for quantifying Bcl-2/IgH breakpoints in follicular lymphoma . BLOOD vol. 98 , ( 11 ) 126A - 126A .
Snaddon J, Arch R, Sutcliffe K, Lister TA, Fitzgibbon J ( 2001 ) . Identification of several novel polymorphisms in the low affinity FC inhibitory receptor FCGR2B . BLOOD vol. 98 , ( 11 ) 164B - 164B .
Snaddon J, Neat M, Smith ML, Rohatiner AZ, Lister TA, Fitzgibbon J ( 2001 ) . Mutations in the runt domain of CBFA2 in myeloid malignancies with acquired trisomy 21 . BLOOD vol. 98 , ( 11 ) 195B - 195B .
Snaddon J, Smith ML, Neat M, Arch R, Cambal-Parrales M, Amess JA, Rohatiner AZ, Lister TA et al. ( 2001 ) . Mutations of CEBPA in acute myeloid leukaemia FAB-type M1 and M2 . BLOOD vol. 98 , ( 11 ) 195B - 195B .
Davies AJ, Summers KE, Matthews J, Jenner MJ, Amess JA, Norton AJ, Rohatiner AZ, Fitzgibbon J et al. ( 2001 ) . The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real time PCR . BLOOD vol. 98 , ( 11 ) 124A - 125A .
Neat MJ, Foot N, Jenner M, Goff L, Ashcroft K, Burford D, Dunham A, Norton A et al. ( 2001 ) . Localisation of a novel region of recurrent amplification in, follicular lymphoma to an similar to 6.8 Mb region of 13q32-33 . GENE CHROMOSOME CANC vol. 32 , ( 3 ) 236 - 243 .
Foot N, Neat M, Jenner M, Goff L, Dunham I, Ross M, Fitzgibbon J, Lister TA ( 2001 ) . Localisation of a novel region of amplification in follicular lymphoma tumours to a 24cR region of human chromosome 13 . J MED GENET vol. 38 , S44 - S44 .
Last KW, Cornelius V, Delves T, Fitzgibbon J, Wilson A, Rohatiner AZS, Lister TA ( 2001 ) . Presentation serum selenium predicts for overall survival in patients with diffuse large B-cell (DLBC) lymphoma . BRIT J CANCER vol. 85 , 59 - 59 .
Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J ( 2001 ) . Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma . J Clin Oncol vol. 19 , ( 2 ) 420 - 424 .
Fitzgibbon J, Hill AS, Arch RS ( 2000 ) . Identification of a novel polymorphism in the human FCGR2B gene: Correlation with response to rituximab treatment in patients with follicular lymphoma . Blood vol. 96 , ( 11 PART II )
Jenner MJ, Matthews J, Summers K, Young BD, Fitzgibbon J, Lister A ( 2000 ) . Application of real time PCR to establishing clonality of Bcl-2 rearrangements in patients with follicular lymphoma . BLOOD vol. 96 , ( 11 ) 332A - 332A .
Fitzgibbon J, Hill AS, Arch RS, Sutcliffe C, Summers KE, Lister A ( 2000 ) . Identification of a novel polymorphism in the human FCGR2B gene: Correlation with response to Rituximab treatment in patients with follicular lymphoma . BLOOD vol. 96 , ( 11 ) 179B - 179B .
Neat M, Foot N, Jenner M, Goff L, Ashcroft K, Burford D, Dunham A, Fitzgibbon J et al. ( 2000 ) . Localisation of a novel region of amplification in follicular lymphoma to an similar to 6.8 Mb region of human chromosome 13q32-33 . BLOOD vol. 96 , ( 11 ) 87A - 87A .
Last KW, Cornelius VR, Delves T, Fitzgibbon J, Wilson A, Rohatiner AZ, Lister A ( 2000 ) . Presentation serum selenium predicts for overall survival in patients with diffuse large B-cell (DLBC) lymphoma . BLOOD vol. 96 , ( 11 ) 335A - 335A .
Last KW, Goff LK, Summers KE, Neat M, Jenner M, Crawley C, Rohatiner AZ, Fitzgibbon J et al. ( 2000 ) . Familial follicular lymphoma: A case report with molecular analysis [2] . British Journal of Haematology vol. 110 , ( 3 ) 744 - 745 .
Fitzgibbon J, Neat MJ, Jones L, Foot N, Lister TA, Gupta RK ( 2000 ) . Assignment of B-cell lymphoma 6, member B (zinc finger protein) gene (BCL6B) to human chromosome 17p13.1 by in situ hybridization . Cytogenetics and Cell Genetics vol. 89 , ( 3-4 ) 218 - 219 .
Fitzgibbon J, Neat MJ, Foot N, Hill AS, Lister TA, Gupta RK ( 2000 ) . Assignment of brain acid-soluble protein 1 (BASP1) to human chromosome 5p15.1· p14, differential expression in human cancer cell lines as a result of alterations in gene dosage . Cytogenetics and Cell Genetics vol. 89 , ( 3-4 ) 147 - 149 .
Fitzgibbon J, Grenzelias D, Matthews J, Andrew Lister T, Gupta RK ( 1999 ) . Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma . British Journal of Haematology vol. 107 , ( 2 ) 388 - 391 .
Halford S, Dulai KS, Daw SC, Fitzgibbon J, Hunt DM ( 1998 ) . Isolation and chromosomal localization of two human CDP-diacylglycerol synthase (CDS) genes . Genomics vol. 54 , ( 1 ) 140 - 144 .
Hunt DM, Fitzgibbon J, Slobodyanyuk SJ, Bowmaker JK, Dulai KS ( 1997 ) . Molecular Evolution of the Cottoid Fish Endemic to Lake Baikal Deduced from Nuclear DNA Evidence . Molecular Phylogenetics and Evolution vol. 8 , ( 3 ) 415 - 422 .
Katsanis N, Fitzgibbon J, Fisher EMC ( 1996 ) . Paralogy mapping: Identification of a region in the human MHC triplicated onto human chromosomes 1 and 9 allows the prediction and isolation of novel PBX and NOTCH loci . Genomics vol. 35 , ( 1 ) 101 - 108 .
Fitzgibbon J, Katsanis N, Wells D, Delhanty J, Vallins W, Hunt DM ( 1996 ) . Human guanylate kinase (GUK1): cDNA sequence, expression and chromosomal localisation . FEBS Letters vol. 385 , ( 3 ) 185 - 188 .
Hunt DM, Fitzgibbon J, Slobodyanyuk SJ, Bowmaker JK ( 1996 ) . Spectral tuning and molecular evolution of rod visual pigments in the species flock of cottoid fish in Lake Baikal . Vision Research vol. 36 , ( 9 ) 1217 - 1224 .
Fitzgibbon J, Hope A, Slobodyanyuk SJ, Bellingham J, Bowmaker JK, Hunt DM ( 1995 ) . The rhodopsin-encoding gene of bony fish lacks introns . Gene vol. 164 , ( 2 ) 273 - 277 .
Woodward K, Nahmias J, Hornigold N, West L, Pilz A, Benham F, Kwiatkowski D, Fitzgibbon J et al. ( 1995 ) . Regional localization of 64 cosmid contigs, including 18 genes and 14 markers, to intervals on human chromosome 9q34 . Genomics vol. 29 , ( 1 ) 257 - 260 .
Pilz A, Schaap D, Hunt D, Fitzgibbon J ( 1995 ) . Chromosomal localization of three mouse diacylglycerol kinase (DAGK) genes: genes sharing sequence homology to the Drosophila retinal degeneration A (rdgA) gene . Genomics vol. 26 , ( 3 ) 599 - 601 .
Nahmias J, Hornigold N, Fitzgibbon J, Woodward K, Pilz A, Griffin D, Henske EP, Nakamura Y et al. ( 1995 ) . Cosmid contigs spanning 9q34 including the candidate region for TSC1 . European Journal of Human Genetics vol. 3 , ( 2 ) 65 - 77 .
Fitzgibbon J, Wells D, Pilz A, Delhanty J, Kai M, Kanoh H, Hunt D ( 1995 ) . Localisation of the gene encoding diacylglycerol kinase 3 (DAGK3) to human chromosome 3q27-28 and mouse chromosome 16 . Current Eye Research vol. 14 , ( 11 ) 1041 - 1043 .
Fitzgibbon J, Appukuttan B, Gayther S, Wells D, Delhanty J, Hunt DM ( 1994 ) . Localisation of the human blue cone pigment gene to chromosome band 7q31.3-32 . Human Genetics vol. 93 , ( 1 ) 79 - 80 .
Fitzgibbon J, Pilz A, Gayther S, Appukuttan B, Dulai KS, Delhanty JDA, Helmkamp GM, Yarbrough LR et al. ( 1994 ) . Localization of the gene encoding human phosphatidylinositol transfer protein (PITPIM) to 17p13.3: A gene showing homology to the Drosophila retinal degeneration B gene (rdgB) . Cytogenetic and Genome Research vol. 67 , ( 3 ) 205 - 207 .
JONES KA, FITZGIBBON J, WOODWARD KJ, GOUDIE D, FERGUSON¿SMITH MA, POVEY S, WOLFE J, SOLOMON E ( 1993 ) . Localization of the retinoid X receptor alpha gene (RXRA) to chromosome 9q34 . Annals of Human Genetics vol. 57 , ( 3 ) 195 - 201 .
FITZGIBBON J, GILLETT GT, WOODWARD KJ, BOYLE JM, WOLFE J, POVEY S ( 1993 ) . Mapping of RXRB to human chromosome 6p21. 3 . Annals of Human Genetics vol. 57 , ( 3 ) 203 - 209 .
Degen SJF, Schaefer LA, Jamison CS, Grant SG, Fitzgibbon JJ, Pai JA, Chapman VM, Elliott RW ( 1990 ) . Characterization of the cDNA Coding for Mouse Prothrombin and Localization of the Gene on Mouse Chromosome 2 . DNA and Cell Biology vol. 9 , ( 7 ) 487 - 498 .